Leonardo Roever: Non-LDL Biomarkers and The Potential Future Applications for 2ry Stroke Prevention
Leonardo Roever, CEO of Brazilian Evidence-Based Health Network, shared on LinkedIn about a recent article by Sean Michael Kelly et al, published in Current Atherosclerosis Reports, adding:
”Rethinking Lipid Burden and the Role of Non-LDL Biomarkers in Stroke Risk Stratification
This article reviews the existing literature on non-LDL biomarkers in atherosclerotic cardiovascular disease (ASCVD), atherogenesis, and ischemic stroke risk, including a discussion on potential future applications for secondary stroke prevention.”
Title: Rethinking Lipid Burden and the Role of Non-LDL Biomarkers in Stroke Risk Stratification
Authors: Sean Michael Kelly, Julia Schneider, Michela Rosso, Koto Ishida, Sara Rostanski, Gregory Katz
Stay updated on all scientific advances with Hemostasis Today.
-
Jul 26, 2026, 07:20Pablo Corral: Why Should Dyslipidemia Be Any Different?
-
Jul 26, 2026, 06:46Marios Georgakis: Largest GWAS of Transient Ischemic Attacks Reveals New Genetic Insights into Stroke Risk
-
Jul 26, 2026, 06:40Aaron Iding: From Virtual Meetings to Meaningful Connections at ISTH 2026
-
Jul 26, 2026, 06:36How Stroke Services Have Evolved Over the Past 8 Years in Kazakhstan – International Journal of Stroke
-
Jul 26, 2026, 06:27Chiara Terzo: New Insights into Haemodialysis in Haemophilia B
-
Jul 26, 2026, 06:20Abdul Hanan: Why Do Patients with Immune TTP Behave Differently ?
-
Jul 26, 2026, 04:56Abdul Mannan: Postpartum Bleeding Is Not Always Obstetric Bleeding
-
Jul 26, 2026, 04:52David Benjamin Joseph: Challenges of Managing Refractory Thrombocytopenia During Pregnancy
-
Jul 26, 2026, 01:48Rob Maloney: Why Global Diagnosis is the Missing Piece in Bleeding Disorder Care